The Grief Navigation Trial: A multi-site pragmatic comparative effectiveness trial of two interventions to support parents after their child's unexpected or traumatic death
Elaf Agha , Carolyn Sutter , Ifeoluwadolapo Ojewuyi , Emily M. Abramsohn , Megan Andriano , Christal Bell , Anna L. Calix , Jamie Lynn Cherry , Kim Downing , Tina Flower , Michelle Halm , Ashley Hayes , Marie E. Heffernan , JaShawn Hill , C. Zoe Hoeppner , Meghan Jacobson , Jacquelyn Jennings , Leslie Kula-Leitner , SuYeon Lee , Deborah R. Major , Ryan Westerberg
{"title":"The Grief Navigation Trial: A multi-site pragmatic comparative effectiveness trial of two interventions to support parents after their child's unexpected or traumatic death","authors":"Elaf Agha , Carolyn Sutter , Ifeoluwadolapo Ojewuyi , Emily M. Abramsohn , Megan Andriano , Christal Bell , Anna L. Calix , Jamie Lynn Cherry , Kim Downing , Tina Flower , Michelle Halm , Ashley Hayes , Marie E. Heffernan , JaShawn Hill , C. Zoe Hoeppner , Meghan Jacobson , Jacquelyn Jennings , Leslie Kula-Leitner , SuYeon Lee , Deborah R. Major , Ryan Westerberg","doi":"10.1016/j.cct.2025.107962","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In the US, ~60,000 people <25 years old die annually. Forty-five percent of pediatric deaths occur traumatically, and the parents' or caregivers' (hereafter ‘parents’) sole contact with the healthcare system is often the coroner or medical examiner (ME). Parents experience mental and physical health problems following their child's death. There are no evidence-based interventions for MEs supporting bereaved parents. Scalable, systems-level interventions are needed to connect bereaved parents to grief and social care support. This research will build upon the experience of Missing Pieces, a community organization that supports families after pediatric death, and CommunityRX, an evidence-based social care intervention that supports patients and caregivers. This comparative effectiveness trial will test two strategies that help parents and caregivers find support after traumatic or unexpected pediatric death.</div></div><div><h3>Methods</h3><div>This pragmatic, comparative effectiveness randomized controlled trial uses a hybrid type 1 implementation-effectiveness design to compare: (1) CommunityRx-Bereavement (the “high touch” intervention), a personalized resource referral intervention involving Grief Navigator support; and (2) general bereavement support information (the “low touch” intervention), including community resources, shared by text message. Parents of deceased children (<25 years old) are referred by MEs to Missing Pieces and cases are randomized. The primary outcomes are complicated grief and self-efficacy for finding resources, evaluated ~6.5 months post-child's death. By taking a community-engaged research approach, community collaborators were included to inform research methods, materials, and dissemination plans.</div></div><div><h3>Discussion</h3><div>This work fills a knowledge gap regarding evidence-based practices for supporting families after the traumatic or unexpected death of their child.</div></div><div><h3>Trial registration</h3><div><span><span>NCT06136260</span><svg><path></path></svg></span>.</div></div>","PeriodicalId":10636,"journal":{"name":"Contemporary clinical trials","volume":"155 ","pages":"Article 107962"},"PeriodicalIF":1.9000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contemporary clinical trials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551714425001569","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background
In the US, ~60,000 people <25 years old die annually. Forty-five percent of pediatric deaths occur traumatically, and the parents' or caregivers' (hereafter ‘parents’) sole contact with the healthcare system is often the coroner or medical examiner (ME). Parents experience mental and physical health problems following their child's death. There are no evidence-based interventions for MEs supporting bereaved parents. Scalable, systems-level interventions are needed to connect bereaved parents to grief and social care support. This research will build upon the experience of Missing Pieces, a community organization that supports families after pediatric death, and CommunityRX, an evidence-based social care intervention that supports patients and caregivers. This comparative effectiveness trial will test two strategies that help parents and caregivers find support after traumatic or unexpected pediatric death.
Methods
This pragmatic, comparative effectiveness randomized controlled trial uses a hybrid type 1 implementation-effectiveness design to compare: (1) CommunityRx-Bereavement (the “high touch” intervention), a personalized resource referral intervention involving Grief Navigator support; and (2) general bereavement support information (the “low touch” intervention), including community resources, shared by text message. Parents of deceased children (<25 years old) are referred by MEs to Missing Pieces and cases are randomized. The primary outcomes are complicated grief and self-efficacy for finding resources, evaluated ~6.5 months post-child's death. By taking a community-engaged research approach, community collaborators were included to inform research methods, materials, and dissemination plans.
Discussion
This work fills a knowledge gap regarding evidence-based practices for supporting families after the traumatic or unexpected death of their child.
期刊介绍:
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.